Skip to main content
Fig. 3 | Cardio-Oncology

Fig. 3

From: Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studyAuthors and Affiliation

Fig. 3

Representative serial inflammatory biomarker on a patient who developed atrial fibrillation

An example of patient with serial inflammatory cytokines are measured at baseline and serially after CAR-T therapy. Patient developed cytokine release syndrome (CRS) grade 1 starting day 3 until day 5. On day 4, patient developed atrial fibrillation, and received tocilizumab for persistent CRS.

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us